Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies

Core Insights - Catalyst Pharmaceuticals, Inc. has been recognized in Forbes' list of America's Most Successful Small-Cap Companies for 2026, ranking 11 out of 100 [1][2] Company Overview - Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients with rare and difficult-to-treat diseases [1][3] - The company has a proven track record of bringing life-changing treatments to market and prioritizes patient care through comprehensive support services [3] - Catalyst has been recognized by Forbes as one of America's Most Successful Companies in 2023, 2024, and 2025, and was listed in the 2025 Deloitte Technology Fast 500™ as one of North America's Fastest-Growing Companies [3] Recognition Criteria - Forbes compiled the list using data from FactSet, focusing on companies with a market value between $300 million and $5 billion, positive sales growth over the past 12 months, and a share price of at least $5 [2] - The ranking was based on earnings growth, sales growth, return on equity, and total stock return over the last five years, with more weight given to the last 12 months of data [2]